Global Tafamidis Drugs Market Growth 2026-2032

July 2026 | 75 pages | ID: GD48C9574EF1EN
LP Information

Abstracts

The global Tafamidis Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Tafamidis is a pharmaceutical drug prescribed primarily for the treatment of transthyretin amyloidosis(ATTR),a rare and debilitating condition characterized by the abnormal accumulation of transthyretin protein in various tissues.By stabilizing transthyretin tetramers,Tafamidis helps prevent the formation of amyloid fibrils,which are the hallmark of the disease and lead to organ dysfunction,particularly affecting the heart and nerves.

United States market for Tafamidis Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Tafamidis Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Tafamidis Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Tafamidis Drugs players cover Pfizer, Qilu pharmaceutical, Chia Tai Tianqing Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Tafamidis Drugs Industry Forecast? looks at past sales and reviews total world Tafamidis Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Tafamidis Drugs sales for 2026 through 2032. With Tafamidis Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tafamidis Drugs industry.

This Insight Report provides a comprehensive analysis of the global Tafamidis Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tafamidis Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Tafamidis Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tafamidis Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tafamidis Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Tafamidis Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Tafamidis Free Acid
• Tafamidis Meglumine

Segmentation by Application:

• ATTR-PN
• ATTR-CM
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Pfizer
• Qilu pharmaceutical
• Chia Tai Tianqing Pharmaceutical

Key Questions Addressed in this Report

• What is the 10-year outlook for the global Tafamidis Drugs market?
• What factors are driving Tafamidis Drugs market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Tafamidis Drugs market opportunities vary by end market size?
• How does Tafamidis Drugs break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Tafamidis Drugs Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Tafamidis Drugs by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Tafamidis Drugs by Country/Region, 2021, 2025 & 2032
2.2 Tafamidis Drugs Segment by Type
  2.2.1 Tafamidis Free Acid
  2.2.2 Tafamidis Meglumine
  2.2.3 Tafamidis Drugs Sales by Type
    2.2.3.1 Global Tafamidis Drugs Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Tafamidis Drugs Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Tafamidis Drugs Sale Price by Type (2021-2026)
2.3 Tafamidis Drugs Segment by Application
  2.3.1 ATTR-PN
  2.3.2 ATTR-CM
  2.3.3 Other
  2.3.4 Tafamidis Drugs Sales by Application
    2.3.4.1 Global Tafamidis Drugs Sale Market Share by Application (2021-2026)
    2.3.4.2 Global Tafamidis Drugs Revenue and Market Share by Application (2021-2026)
    2.3.4.3 Global Tafamidis Drugs Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Tafamidis Drugs Breakdown Data by Company
  3.1.1 Global Tafamidis Drugs Annual Sales by Company (2021-2026)
  3.1.2 Global Tafamidis Drugs Sales Market Share by Company (2021-2026)
3.2 Global Tafamidis Drugs Annual Revenue by Company (2021-2026)
  3.2.1 Global Tafamidis Drugs Revenue by Company (2021-2026)
  3.2.2 Global Tafamidis Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Tafamidis Drugs Sale Price by Company
3.4 Key Manufacturers Tafamidis Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Tafamidis Drugs Product Location Distribution
  3.4.2 Players Tafamidis Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR TAFAMIDIS DRUGS BY GEOGRAPHIC REGION

4.1 World Historic Tafamidis Drugs Market Size by Geographic Region (2021-2026)
  4.1.1 Global Tafamidis Drugs Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Tafamidis Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Tafamidis Drugs Market Size by Country/Region (2021-2026)
  4.2.1 Global Tafamidis Drugs Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Tafamidis Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Tafamidis Drugs Sales Growth
4.4 APAC Tafamidis Drugs Sales Growth
4.5 Europe Tafamidis Drugs Sales Growth
4.6 Middle East & Africa Tafamidis Drugs Sales Growth

5 AMERICAS

5.1 Americas Tafamidis Drugs Sales by Country
  5.1.1 Americas Tafamidis Drugs Sales by Country (2021-2026)
  5.1.2 Americas Tafamidis Drugs Revenue by Country (2021-2026)
5.2 Americas Tafamidis Drugs Sales by Type (2021-2026)
5.3 Americas Tafamidis Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Tafamidis Drugs Sales by Region
  6.1.1 APAC Tafamidis Drugs Sales by Region (2021-2026)
  6.1.2 APAC Tafamidis Drugs Revenue by Region (2021-2026)
6.2 APAC Tafamidis Drugs Sales by Type (2021-2026)
6.3 APAC Tafamidis Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Tafamidis Drugs by Country
  7.1.1 Europe Tafamidis Drugs Sales by Country (2021-2026)
  7.1.2 Europe Tafamidis Drugs Revenue by Country (2021-2026)
7.2 Europe Tafamidis Drugs Sales by Type (2021-2026)
7.3 Europe Tafamidis Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Tafamidis Drugs by Country
  8.1.1 Middle East & Africa Tafamidis Drugs Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Tafamidis Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Tafamidis Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Tafamidis Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tafamidis Drugs
10.3 Manufacturing Process Analysis of Tafamidis Drugs
10.4 Industry Chain Structure of Tafamidis Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Tafamidis Drugs Distributors
11.3 Tafamidis Drugs Customer

12 WORLD FORECAST REVIEW FOR TAFAMIDIS DRUGS BY GEOGRAPHIC REGION

12.1 Global Tafamidis Drugs Market Size Forecast by Region
  12.1.1 Global Tafamidis Drugs Forecast by Region (2027-2032)
  12.1.2 Global Tafamidis Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Tafamidis Drugs Forecast by Type (2027-2032)
12.7 Global Tafamidis Drugs Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Pfizer
  13.1.1 Pfizer Company Information
  13.1.2 Pfizer Tafamidis Drugs Product Portfolios and Specifications
  13.1.3 Pfizer Tafamidis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Pfizer Main Business Overview
  13.1.5 Pfizer Latest Developments
13.2 Qilu pharmaceutical
  13.2.1 Qilu pharmaceutical Company Information
  13.2.2 Qilu pharmaceutical Tafamidis Drugs Product Portfolios and Specifications
  13.2.3 Qilu pharmaceutical Tafamidis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Qilu pharmaceutical Main Business Overview
  13.2.5 Qilu pharmaceutical Latest Developments
13.3 Chia Tai Tianqing Pharmaceutical
  13.3.1 Chia Tai Tianqing Pharmaceutical Company Information
  13.3.2 Chia Tai Tianqing Pharmaceutical Tafamidis Drugs Product Portfolios and Specifications
  13.3.3 Chia Tai Tianqing Pharmaceutical Tafamidis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Chia Tai Tianqing Pharmaceutical Main Business Overview
  13.3.5 Chia Tai Tianqing Pharmaceutical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Tafamidis Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Tafamidis Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Tafamidis Free Acid
Table 4. Major Players of Tafamidis Meglumine
Table 5. Global Tafamidis Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global Tafamidis Drugs Sales Market Share by Type (2021-2026)
Table 7. Global Tafamidis Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global Tafamidis Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global Tafamidis Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Tafamidis Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global Tafamidis Drugs Sale Market Share by Application (2021-2026)
Table 12. Global Tafamidis Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global Tafamidis Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global Tafamidis Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Tafamidis Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global Tafamidis Drugs Sales Market Share by Company (2021-2026)
Table 17. Global Tafamidis Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Tafamidis Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global Tafamidis Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Tafamidis Drugs Producing Area Distribution and Sales Area
Table 21. Players Tafamidis Drugs Products Offered
Table 22. Tafamidis Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Tafamidis Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Tafamidis Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global Tafamidis Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Tafamidis Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Tafamidis Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Tafamidis Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global Tafamidis Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Tafamidis Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Tafamidis Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas Tafamidis Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas Tafamidis Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Tafamidis Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas Tafamidis Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC Tafamidis Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC Tafamidis Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC Tafamidis Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Tafamidis Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC Tafamidis Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe Tafamidis Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe Tafamidis Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Tafamidis Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe Tafamidis Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Tafamidis Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Tafamidis Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Tafamidis Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Tafamidis Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Tafamidis Drugs
Table 52. Key Market Challenges & Risks of Tafamidis Drugs
Table 53. Key Industry Trends of Tafamidis Drugs
Table 54. Tafamidis Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Tafamidis Drugs Distributors List
Table 57. Tafamidis Drugs Customer List
Table 58. Global Tafamidis Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Tafamidis Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Tafamidis Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Tafamidis Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Tafamidis Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Tafamidis Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Tafamidis Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Tafamidis Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Tafamidis Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Tafamidis Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Tafamidis Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Tafamidis Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Tafamidis Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Tafamidis Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Pfizer Basic Information, Tafamidis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer Tafamidis Drugs Product Portfolios and Specifications
Table 74. Pfizer Tafamidis Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. Qilu pharmaceutical Basic Information, Tafamidis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Qilu pharmaceutical Tafamidis Drugs Product Portfolios and Specifications
Table 79. Qilu pharmaceutical Tafamidis Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Qilu pharmaceutical Main Business
Table 81. Qilu pharmaceutical Latest Developments
Table 82. Chia Tai Tianqing Pharmaceutical Basic Information, Tafamidis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Chia Tai Tianqing Pharmaceutical Tafamidis Drugs Product Portfolios and Specifications
Table 84. Chia Tai Tianqing Pharmaceutical Tafamidis Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Chia Tai Tianqing Pharmaceutical Main Business
Table 86. Chia Tai Tianqing Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Tafamidis Drugs
Figure 2. Tafamidis Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tafamidis Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Tafamidis Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Tafamidis Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Tafamidis Drugs Sales Market Share by Country/Region (2025)
Figure 10. Tafamidis Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Tafamidis Free Acid
Figure 12. Product Picture of Tafamidis Meglumine
Figure 13. Global Tafamidis Drugs Sales Market Share by Type in 2026
Figure 14. Global Tafamidis Drugs Revenue Market Share by Type (2021-2026)
Figure 15. Tafamidis Drugs Consumed in ATTR-PN
Figure 16. Global Tafamidis Drugs Market: ATTR-PN (2021-2026) & (K Units)
Figure 17. Tafamidis Drugs Consumed in ATTR-CM
Figure 18. Global Tafamidis Drugs Market: ATTR-CM (2021-2026) & (K Units)
Figure 19. Tafamidis Drugs Consumed in Other
Figure 20. Global Tafamidis Drugs Market: Other (2021-2026) & (K Units)
Figure 21. Global Tafamidis Drugs Sale Market Share by Application (2025)
Figure 22. Global Tafamidis Drugs Revenue Market Share by Application in 2026
Figure 23. Tafamidis Drugs Sales by Company in 2026 (K Units)
Figure 24. Global Tafamidis Drugs Sales Market Share by Company in 2026
Figure 25. Tafamidis Drugs Revenue by Company in 2026 ($ millions)
Figure 26. Global Tafamidis Drugs Revenue Market Share by Company in 2026
Figure 27. Global Tafamidis Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Tafamidis Drugs Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Tafamidis Drugs Sales 2021-2026 (K Units)
Figure 30. Americas Tafamidis Drugs Revenue 2021-2026 ($ millions)
Figure 31. APAC Tafamidis Drugs Sales 2021-2026 (K Units)
Figure 32. APAC Tafamidis Drugs Revenue 2021-2026 ($ millions)
Figure 33. Europe Tafamidis Drugs Sales 2021-2026 (K Units)
Figure 34. Europe Tafamidis Drugs Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Tafamidis Drugs Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Tafamidis Drugs Revenue 2021-2026 ($ millions)
Figure 37. Americas Tafamidis Drugs Sales Market Share by Country in 2026
Figure 38. Americas Tafamidis Drugs Revenue Market Share by Country (2021-2026)
Figure 39. Americas Tafamidis Drugs Sales Market Share by Type (2021-2026)
Figure 40. Americas Tafamidis Drugs Sales Market Share by Application (2021-2026)
Figure 41. United States Tafamidis Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Tafamidis Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Tafamidis Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Tafamidis Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Tafamidis Drugs Sales Market Share by Region in 2026
Figure 46. APAC Tafamidis Drugs Revenue Market Share by Region (2021-2026)
Figure 47. APAC Tafamidis Drugs Sales Market Share by Type (2021-2026)
Figure 48. APAC Tafamidis Drugs Sales Market Share by Application (2021-2026)
Figure 49. China Tafamidis Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Tafamidis Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Tafamidis Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Tafamidis Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. India Tafamidis Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Tafamidis Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Tafamidis Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Tafamidis Drugs Sales Market Share by Country in 2026
Figure 57. Europe Tafamidis Drugs Revenue Market Share by Country (2021-2026)
Figure 58. Europe Tafamidis Drugs Sales Market Share by Type (2021-2026)
Figure 59. Europe Tafamidis Drugs Sales Market Share by Application (2021-2026)
Figure 60. Germany Tafamidis Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. France Tafamidis Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Tafamidis Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Tafamidis Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Tafamidis Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Tafamidis Drugs Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Tafamidis Drugs Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Tafamidis Drugs Sales Market Share by Application (2021-2026)
Figure 68. Egypt Tafamidis Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Tafamidis Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Tafamidis Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Tafamidis Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Tafamidis Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Tafamidis Drugs in 2026
Figure 74. Manufacturing Process Analysis of Tafamidis Drugs
Figure 75. Industry Chain Structure of Tafamidis Drugs
Figure 76. Channels of Distribution
Figure 77. Global Tafamidis Drugs Sales Market Forecast by Region (2027-2032)
Figure 78. Global Tafamidis Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Tafamidis Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Tafamidis Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Tafamidis Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Tafamidis Drugs Revenue Market Share Forecast by Application (2027-2032)